Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The compan…
Insiders
Transactions
Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra | ||
---|---|---|---|---|---|---|---|
$11,760
d
Common Stock, $0.10 par value
10% Holder
|
11/04/24 |
S
|
700 x $55.62 = $38,934.00 |
Footnotes
|
|||
$104,114
d
Common Stock, $0.10 par value
10% Holder
|
11/01/24 |
J
|
55 x $0 = $0 |
Footnotes
#1 Represents vesting of one-quarter of market share units granted on November 1, 2023.
#2 Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.
#3 Shares withheld for payment of taxes upon vesting of awards.
|
|||
$102,626
d
Common Stock, $0.10 par value
10% Holder
|
11/01/24 |
F
|
1,488 x $54.32 = $80,828.16 |
Footnotes
#1 Represents vesting of one-quarter of market share units granted on November 1, 2023.
#2 Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.
#3 Shares withheld for payment of taxes upon vesting of awards.
|
|||
$62,109
d
Common Stock, $0.10 par value
10% Holder
|
11/01/24 |
P
|
1,830 x $54.67 = $100,046.10 |
Footnotes
|
|||
$104,169
d
Common Stock, $0.10 par value
10% Holder
|
11/01/24 |
M
|
2,964 x $0 = $0 |
Footnotes
#1 Represents vesting of one-quarter of market share units granted on November 1, 2023.
#2 Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.
#3 Shares withheld for payment of taxes upon vesting of awards.
|
Get PRO Today
With PRO you will unlock 107 more insider transactions for Bristol-Myers Squibb Company
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Arduini Peter J Director
- Bhatt Deepak Director
- Boerner Christopher S. Chief Executive Officer
- Caforio Giovanni Executive Chair of the Board
- Elkins David V EVP, Chief Financial Officer
- Gallman Cari EVP, Corporate Affairs
- Haller Julia A Director
- Hickey Benjamin President, RayzeBio Org.
- Hidalgo Medina Manuel Director
- Hirawat Samit EVP,Chief Med.Offr.,Drug Dev.
- Hoch Lynelle President, Cell Therapy Org.
- Holzer Phil M SVP and Controller
- Lenkowsky Adam EVP, Chief Commercial Officer
- Leung Sandra EVP, General Counsel
- Mcmullen Michael R. Director
- Meyers Gregory Scott EVP, Chief Digital & Tech Off.
- Plenge Robert M EVP, Chief Research Officer
- Poole Ahn Amanda EVP, Chief Human Resources
- Price Paula A Director
- Rice Derica W Director
- Samuels Theodore R. Ii Director
- Shanahan Karin EVP, Glob. Prod. Dev. & Supply
- Storch Gerald L Director
- Vousden Karen H Director
- Yale Phyllis R Director
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Arduini Peter J Director
- Bhatt Deepak Director
- Boerner Christopher S. Chief Executive Officer
- Caforio Giovanni Executive Chair of the Board
- Elkins David V EVP, Chief Financial Officer
- Gallman Cari EVP, Corporate Affairs
- Haller Julia A Director
- Hickey Benjamin President, RayzeBio Org.
- Hidalgo Medina Manuel Director
- Hirawat Samit EVP,Chief Med.Offr.,Drug Dev.
- Hoch Lynelle President, Cell Therapy Org.
- Holzer Phil M SVP and Controller
- Lenkowsky Adam EVP, Chief Commercial Officer
- Leung Sandra EVP, General Counsel
- Mcmullen Michael R. Director
- Meyers Gregory Scott EVP, Chief Digital & Tech Off.
- Plenge Robert M EVP, Chief Research Officer
- Poole Ahn Amanda EVP, Chief Human Resources
- Price Paula A Director
- Rice Derica W Director
- Samuels Theodore R. Ii Director
- Shanahan Karin EVP, Glob. Prod. Dev. & Supply
- Storch Gerald L Director
- Vousden Karen H Director
- Yale Phyllis R Director